BofA raised the firm’s price target on Option Care Health (OPCH) to $35 from $32 and keeps a Buy rating on the shares after hosting CFO Meenal Sethna and Chief Accounting Officer Nicole Maggio at the firm’s Home Care Conference. While 2026 may not fully hit the company’s long-term growth algorithm due to Stelara, Option expects “solid growth” next year and remains confident in the long-term, the analyst tells investors following the event.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health price target raised to $36 from $31 at Deutsche Bank
- Option Care Health: Strong Growth Prospects and Strategic Initiatives Drive Buy Rating
- Option Care Health management to meet with Truist
- Option Care Health price target lowered to $27 from $30 at TD Cowen
- Option Care Health’s Earnings Call Highlights Growth and Challenges